Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Cecilia Butini BioNTech SE on Monday posted lower revenue and profit for the fourth quarter of 2022, and said it expects a fall in revenue from its Covid-19 vaccines in the current year. ... | March 27, 2023
BioNTech expects revenue from its COVID-19 vaccines to hit €5bn (US$5.3bn) in 2023, which would be lower than market expectations.
Like Moderna and Pfizer, the biotech company is turning its covid windfall to the quest for new cancer treatments
BioNTech and OncoC4 have announced a worldwide license and collaboration agreement to develop and commercialize OncoC4’s next-generation anti-CTLA-4 monoclonal antibody candidate, ONC-392, as monotherapy or combination therapy in various cancer indications.
A USA FDA-approved skin care laser, Picocare 250 Majesty is from Wontech, South Korea, with the aim to redefine the contours of skin laser care and aesthetics in India, uncovering the youthful glow hidden by ageing and skin-related problems.Adding to the expansive array of advanced technology available at DAC http www.doctorsaestheticscentre.com , Picocare 250 Majesty is set to resolve a variety of skin-related procedures with maximum efficiency.